Highlight
This study identifies anti-CD320 autoantibodies as a novel biomarker in idiopathic myelopathy (IM), linked to central nervous system (CNS) vitamin B12 deficiency. The presence of these autoantibodies corresponds with distinct clinical features, a unique MRI pattern, and metabolic evidence of impaired vitamin B12 transport. Vitamin B12 supplementation with or without immunosuppression resulted in clinical improvement in most treated patients, suggesting potential therapeutic avenues.
Specialty calculators
For clinical reference; use professional judgment.

